Form Bio and Cure Rare Disease partner to accelerate genetic medicine

Form Bio and Cure Rare Disease have entered a strategic partnership aimed at speeding development of genetic therapies for rare neuromuscular diseases, beginning with Duchenne muscular dystrophy (DMD). Under the collaboration, Form Bio will leverage its proprietary in silico and AI/ML platform to assist Cure Rare Disease in optimizing adeno-associated virus (AAV) construct designs. The […] The post Form Bio and Cure Rare Disease partner to accelerate genetic medicine appeared first on Longevity.Technology.